BIOEN.E — Biotrend Cevre ve Enerji Yatirimlari AS Balance Sheet
0.000.00%
- TRY9.81bn
- TRY13.34bn
- TRY2.23bn
- 33
- 29
- 61
- 33
Annual balance sheet for Biotrend Cevre ve Enerji Yatirimlari AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | R2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | Interim Report | ARS | Interim Report |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 18.3 | 102 | 171 | 45.5 | 169 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 26 | 38.7 | 130 | 583 | 344 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 65.5 | 237 | 683 | 2,025 | 1,318 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 191 | 474 | 968 | 4,045 | 5,456 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 340 | 815 | 1,832 | 6,644 | 7,673 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 114 | 221 | 474 | 2,008 | 1,846 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 258 | 615 | 1,271 | 4,179 | 4,406 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 82.3 | 200 | 561 | 2,465 | 3,267 |
Total Liabilities & Shareholders' Equity | 340 | 815 | 1,832 | 6,644 | 7,673 |
Total Common Shares Outstanding |